Хайлтын үр дүнгүүд - Jonathan Reuning‐Scherer
- 2-н 1 - 2 үр дүнгүүдийг харуулж байна
-
1
Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial -н Christopher Parker, Lin Zhan, Paul Cislo, Jonathan Reuning‐Scherer, Nicholas J. Vogelzang, Sten Nilsson, Oliver Sartor, Joe M. O’Sullivan, Robert E. Coleman
Хэвлэсэн 2016Artigo -
2
Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study -н Sten Nilsson, Paul Cislo, Oliver Sartor, Nicholas J. Vogelzang, Robert E. Coleman, Joe M. O’Sullivan, Jonathan Reuning‐Scherer, Minghua Shan, Zhan Lu, Chris Parker
Хэвлэсэн 2016Artigo